Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ RCKT′s IND for RP-A701 in Dilated Cardiomyopathy Gets FDA Clearance (Zacks) +++ ROCKET PHARMACEUTICALS Aktie +3,61%

KKR & CO Aktie

 >KKR & CO Aktienkurs 
112.24 EUR    -0.6%    (Tradegate)
Ask: 112.66 EUR / 50 Stück
Bid: 111.98 EUR / 50 Stück
Tagesumsatz: 600 Stück
Realtime Kurs von 8 bis 22 Uhr!
KKR & CO Aktie über LYNX handeln
>KKR & CO Performance
1 Woche: +2,1%
1 Monat: +5,7%
3 Monate: +2,9%
6 Monate: -21,4%
1 Jahr: +14,8%
laufendes Jahr: -21,4%
>KKR & CO Aktie
Name:  KKR & CO INC.
Land:  USA
Sektor:  Finanzen
ISIN/ Wkn:  US48251W1045 / A2LQV6
Symbol/ Ticker:  KR51 (Frankfurt) / KKR (NYSE)
Kürzel:  FRA:KR51, ETR:KR51, KR51:GR, NYSE:KKR
Index:  -
Webseite:  https://www.kkr.com/
Marktkapitalisierung:  93160 Mio. EUR
Umsatz:  17584.26 Mio. EUR
EBITDA:  -
Gewinn je Aktie:  1.732 EUR
Schulden:  44553.73 Mio. EUR
Liquide Mittel:  34926.1 Mio. EUR
Umsatz-/ Gewinnwachstum:  -57.6% / -59.7%
KGV/ KGV lG:  53.56 / 23.81
KUV/ KBV/ PEG:  7.65 / 4.44 / 1.26
Gewinnm./ Eigenkapitalr.:  10.87% / 7.15%
Dividende je Aktie:  0.654 EUR
Dividendenrendite/ -schätzung:  0.6% / 0.61%
Div. Historie:  12.05.25 - 0.16447€
14.02.25 - 0.16721€
>weitere anzeigen...
Insiderhandel:  2 Insider verkauften innerhalb der letzten 30 Tage Aktien im Wert von 296.329.092 USD.
Suchwörter:  KKR & CO, KOHLBERG KRAVIS, KKR
Letzte Datenerhebung:  01.07.25
>KKR & CO Eigentümer
Aktien: 890.64 Mio. St.
f.h. Aktien: 682.64 Mio. St.
Insider Eigner: 23.59%
Instit. Eigner: 61.4%
 >KKR & CO Anleihen 
Es sind 1 Anleihen zur KKR & CO Aktie bekannt.
>KKR & CO Peer Group

 
01.07.25 - 15:12
KKR-Backed Catalio Gathers $400 Million for Biotech Startups (Bloomberg)
 
KKR & Co.-backed venture capital firm Catalio Capital Management gathered more than $400 million for its latest fund, a marginally larger amount than the biotech company raised for its prior vehicle....
01.07.25 - 13:48
Wait-And-See Approach Doesn′t Serve Investors In Time of Volatility, Says KKR′s Alisa Wood (Bloomberg)
 
KKR Partner Alisa Wood says the wait-and-see approach doesn't serve investors in moments of high volatility. She adds the correlation between asset classes has fundamentally shifted and is fostering take-private deals. Wood speaks with Kriti Gupta, Guy Johnson and Anna Edwards on 'Bloomberg: The Opening Trade'. This interview occurred on Wednesday, June 26. (Source: Bloomberg)...
01.07.25 - 08:33
KKR makes second residential investment in Stockholm (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
01.07.25 - 08:03
KKR Makes Second Residential Investment in Stockholm with Three Asset Multifamily Development in Täby (Business Wire)
 
STOCKHOLM--(BUSINESS WIRE)--KKR, a leading global investment firm, today announced the agreement with leading Swedish developer Reliwe for the forward funding of a new multifamily development in Täby, one of Stockholm's most sought-after municipalities. The transaction marks KKR's second residential investment in Sweden's capital region since the beginning of 2025. The project in Täby comprises three residential assets with a total of 325 units and approximately 15,300 square meters of lettable area, expected to be completed in phases between 2026 and 2028. Located just 14 kilometers from Stockholm city center, the asset offers excellent public transport connectivity via a nearby train station, providing access to central Stockholm in under 20 minutes. The development is situated adjacent to Täby Centrum, one of the city's leading shopping centers, and is designed to meet high sustainability and architectural standards. In February, KKR announced its investment in three multifamily properties in Ha...
01.07.25 - 07:06
KKR-backed Ascend Asia buys finexis advisory firm in Singapore (Reuters EN)
 
Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...
01.07.25 - 00:30
15 Analysts Assess KKR: What You Need To Know (Benzinga)
 
Latest Ratings for KKR DateFirmActionFromTo Feb 2022Morgan StanleyMaintainsEqual-Weight Feb 2022Deutsche BankMaintainsBuy Jan 2022Morgan StanleyMaintainsEqual-Weight View More Analyst Ratings for KKR View the Latest Analyst Ratings read more...
29.06.25 - 23:24
Torrent in Rs 18,000 crore deal, 2nd largest in pharma sector (Times of India)
 
Torrent Pharma is set to acquire a controlling stake in JB Chemicals & Pharmaceuticals for approximately Rs 18,000 crore, marking the second-largest pharma deal in India. The acquisition involves purchasing a 46.4% stake from KKR, followed by an open offer to public shareholders. This deal will create India's second most valued pharma company, with substantial revenue and a top-five ranking....
29.06.25 - 21:00
India′s Torrent to buy controlling stake in JB Chemicals from KKR for $1.4B (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
29.06.25 - 18:42
Torrent to Acquire KKR′s Stake in JB Pharma for $1.4 Billion (Bloomberg)
 
Torrent Pharmaceuticals Ltd. agreed to take a controlling stake in JB Chemicals & Pharmaceuticals Ltd. from private equity firm KKR & Co., the latest sign of a dealmaking boom in India....
29.06.25 - 17:54
Torrent Pharma to Acquire Controlling Stake in J. B. Chemicals & Pharmaceuticals from KKR (Business Wire)
 
Acquisition to be followed by merger; strengthens Torrent's IPM market presenceMUMBAI, India--(BUSINESS WIRE)--Torrent Pharmaceuticals Limited (“Torrent”) and global investment firm KKR today announced that Torrent has entered into definitive agreements to acquire controlling stake in J. B. Chemicals and Pharmaceuticals (“JB Pharma”) from KKR at an Equity Valuation of INR 25,689 crores (on fully diluted basis), followed by a merger of the two entities. The transaction marks a significant step in Torrent's ambition to create a future-ready, diversified healthcare platform combining a deep chronic segment heritage with emerging international CDMO capabilities. The transaction will be executed in 2 phases: Acquisition of 46.39% equity stake (on a fully diluted basis) through a Share Purchase Agreement (“SPA”) at a consideration of INR 11,917 crores (INR 1,600 per share) followed by a mandatory open offer to acquire up to 26% of JB Pharma shares from public shareholders at an open offer price of...
28.06.25 - 04:01
Torrent Pharma revives talks to buy KKR stake in JB Chem (Times of India)
 
Um den gesamten Artikel unter timesofindia.indiatimes.com zu lesen, klicken Sie bitte auf die Überschrift...
27.06.25 - 22:18
KKR-backed NIQ files for US IPO (Reuters EN)
 
Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...
27.06.25 - 06:48
Germany′s Plans Are Big, But Not Big Enough, KKR′s Vincent Policard Says (Bloomberg)
 
The German cabinet has approved plans to spend €500B on infrastructure over the next 12 years, but KKR's Vincent Policard says it's not enough. KKR has invested billions in Germany over the past few years, and Policard says private capital will be key. He spoke to Bloomberg's Tom Mackenzie on "Daybreak Europe" on June 25. (Source: Bloomberg)...
26.06.25 - 14:54
Is KKR Stock Outperforming the Nasdaq? (Barchart)
 
As KKR has delivered stronger returns than the broader Nasdaq Composite over the past year, Wall Street analysts maintain a bullish outlook on the stock's prospects....
25.06.25 - 01:12
Why KKR Stock Rocketed Almost 5% Higher Today (Fool)
 
Um den gesamten Artikel unter fool.com zu lesen, klicken Sie bitte auf die Überschrift...
23.06.25 - 17:00
Spectris shares pop as KKR responds to Advent bid (ShareCast)
 
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...
23.06.25 - 14:39
Uber, KKR, Rocket Companies And An Industrial Stock On CNBC€s €Final Trades€ (Benzinga)
 
Hightower's Stephanie Link continues to buy Uber stock, while Ritholtz's Joshua Brown remains long on Rocket Companies. read more...
23.06.25 - 13:24
KKR Nears Buyout of Chinese Beverage Maker Dayao (Bloomberg)
 
KKR & Co. is close to acquiring an 85% stake in Chinese soda maker Dayao, according to people familiar with the situation....
23.06.25 - 09:48
KKR mulls counter-offer after Spectris agrees Advent takeover (Alliance)
 
Spectris PLC on Monday agreed to a £3.8 billion buyout from private equity firm Advent International, although a rival bid from Kohlberg Kravis Roberts &......
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Ein Kasten voll Lügen wird nicht durchs Stadttor gelassen. - Sprichwort China
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!